Skip to main content
Fig. 10 | BMC Cancer

Fig. 10

From: Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma

Fig. 10

IC50 of chemotherapeutic drugs between the high- and low-risk group based on the pyroptosis-related genes signature in TCGA dataset. A Patients in the high-risk group were more sensitive to Axitinib, Dasatinib, Erlotinib, and Lapatinib (p < 0.001). B Patients in the low-risk group were more sensitive to Gemcitabine, Nilotinib, Camptothecin, and Tipifarnib (p < 0.001)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us